JBCHEPHARM — J B Chemicals and Pharmaceuticals Cashflow Statement
0.000.00%
- IN₹251.04bn
- IN₹246.70bn
- IN₹39.18bn
- 100
- 15
- 78
- 74
Annual cashflow statement for J B Chemicals and Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 5,969 | 5,049 | 5,552 | 7,515 | 8,874 |
Depreciation | |||||
Non-Cash Items | -1,148 | 297 | 814 | 489 | 375 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -2,359 | -4,371 | -1,254 | -1,381 | -1,935 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 3,148 | 1,701 | 6,256 | 8,006 | 9,024 |
Capital Expenditures | -478 | -7,068 | -7,649 | -2,614 | -1,203 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -1,829 | 7,091 | -1,968 | -1,425 | -1,756 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -2,307 | 23.2 | -9,618 | -4,038 | -2,959 |
Financing Cash Flow Items | -63.5 | -24.6 | -378 | -442 | -96.2 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -874 | -1,384 | 3,565 | -3,855 | -5,797 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -32.8 | 341 | 204 | 113 | 269 |